(Q27014778)

A. Humar

series ordinal

2

1 reference

D. Kumar

series ordinal

3

1 reference

language of work or name

1 reference

December 2012

1 reference

Clinical Infectious Diseases

published in

1 reference

volume

55

1 reference

issue

12

1 reference

page(s)

1678-89

1 reference

International consensus guidelines on the management of cytomegalovirus in solid organ transplantation

cites work

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

The efficacy and safety of 200 days valganciclovir cytomegalovirus prophylaxis in high-risk kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Long-term outcomes of CMV disease treatment with valganciclovir versus IV ganciclovir in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Cytomegalovirus (CMV) virus load kinetics to predict recurrent disease in solid-organ transplant patients with CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Clinical utility of cytomegalovirus (CMV) serology testing in high-risk CMV D+/R- transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Protection from cytomegalovirus after transplantation is correlated with immediate early 1-specific CD8 T cells

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Cytomegalovirus-specific T-cell responses and viral replication in kidney transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Longitudinal assessment of cytomegalovirus (CMV)-specific immune responses in liver transplant recipients at high risk for late CMV disease

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Serum antibody response to the gH/gL/pUL128-131 five-protein complex of human cytomegalovirus (HCMV) in primary and reactivated HCMV infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

PD-1 expression and IL-2 loss of cytomegalovirus- specific T cells correlates with viremia and reversible functional anergy

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

T cells and viral persistence: lessons from diverse infections

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Primary response against cytomegalovirus during antiviral prophylaxis with valganciclovir, in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Experience with immune monitoring in lung transplant recipients: correlation of low immune function with infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Cell-mediated immunity to predict cytomegalovirus disease in high-risk solid organ transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Broadly targeted human cytomegalovirus-specific CD4+ and CD8+ T cells dominate the memory compartments of exposed subjects

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Narrowing of T-cell receptor beta variable repertoire during symptomatic herpesvirus infection in transplant patients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Efficacy and safety of valganciclovir vs. oral ganciclovir for prevention of cytomegalovirus disease in solid organ transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Extended valganciclovir prophylaxis in D+/R- kidney transplant recipients is associated with long-term reduction in cytomegalovirus disease: two-year results of the IMPACT study

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Extended valganciclovir prophylaxis to prevent cytomegalovirus after lung transplantation: a randomized, controlled trial

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Dominance of virus-specific CD8 T cells in human primary cytomegalovirus infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Primary cytomegalovirus phosphoprotein 65-specific CD8+ T-cell responses and T-bet levels predict immune control during early chronic infection in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Monitoring cytomegalovirus T-cell immunity in small bowel/multivisceral transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Human cytomegalovirus-specific T-cell immune reconstitution in preemptively treated heart transplant recipients identifies subjects at critical risk for infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Ex vivo monitoring of human cytomegalovirus-specific CD8+ T-cell responses using QuantiFERON-CMV.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Quantiferon-CMV test in prediction of cytomegalovirus infection after kidney transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Linking CMV serostatus to episodes of CMV reactivation following lung transplantation by measuring CMV-specific CD8+ T-cell immunity

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Cellular immune responses to cytomegalovirus in renal transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

A prospective longitudinal analysis of cytomegalovirus (CMV)-specific CD4+ and CD8+ T cells in kidney allograft recipients at risk of CMV infection

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Evaluation and significance of cytomegalovirus-specific cellular immune response in lung transplant recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Virologic and immunologic monitoring of cytomegalovirus to guide preemptive therapy in solid-organ transplantation.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Prospective analysis of human cytomegalovirus DNAemia and specific CD8+ T cell responses in lung transplant recipients.

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Dynamics of cell-mediated immune responses to cytomegalovirus in pediatric transplantation recipients

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818

Investigation of promoter variations in dendritic cell-specific ICAM3-grabbing non-integrin (DC-SIGN) (CD209) and their relevance for human cytomegalovirus reactivation and disease after allogeneic stem-cell transplantation

21 January 2018

1 reference

https://api.crossref.org/works/10.1093%2FCID%2FCIS818